beta
ITEK
Inotek Pharmaceuticals Corporation
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Inotek Pharmaceuticals Corp is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye.
Market Cap: 82.8 Million
Primary Exchange: NASDAQ Global Market
Website: http://www.inotekpharma.com
Shares Outstanding: 27.2 Million
Float: 27.1 Million
Dividend: 0.0 (0.0%)
Beta: 3.256384
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 617 trading days
From: 2015-07-24 To: 2018-01-04
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|